Joshua Kiernan is a partner in the London office of Latham & Watkins, focusing on international capital markets transactions, securities regulation, and cross-border mergers and acquisitions.
Mr. Kiernan has extensive experience advising companies on SEC-registered IPOs, follow-on and secondary offerings, block trades, private placements, and Rule 144A offerings. In addition, his practice includes advising on a variety of debt offerings (including high yield and convertible bonds) and cross-border M&A, joint ventures, and leveraged buyouts.
Mr. Kiernan assists many clients with SEC reporting and corporate governance matters and has particular experience in the technology and life sciences sectors.
Mr. Kiernan has advised the issuers and underwriters on IPOs and other securities offerings for the following companies:
- Allot Communications
- Magic Software
- Saifun Semiconductors
- Ayala Pharmaceuticals
- Itamar Medical
- Sol-Gel Technologies
- Foamix Pharmaceuticals